Sat.Feb 04, 2023 - Fri.Feb 10, 2023

article thumbnail

Opinion: Mindstrong’s demise and the future of mental health care

STAT

One of the shinier entrants to have emerged in the world of mental health startups abruptly announced last week it would wind down, right in the middle of an ongoing crisis in mental health care. Mindstrong, which had raised a total of $160 million from a who’s-who of blue-chip investors, and was led for a while by a former National Institute of Mental Health director, simply couldn’t find a way to make money delivering the low-cost, high-quality care it had promised.

342
342
article thumbnail

3 ways the FDA’s restructuring plan could impact pharma

PharmaVoice

FDA’s food program is in for a major overhaul — here’s why pharma should pay attention.

243
243
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Alvotech proposed biosimilar to Stelara accepted by EMA

Pharma Times

The companies anticipate that the EMA could also recommend marketing authorisation for AVT04

article thumbnail

Trick of the Trade: Antibiotic ointment for removal of artificial nail glue from eyelids

ALiEM - Pharm Pearls

A bottle of nail glue and timolol eye drops (reproduced with permission from BMJ Publishing Group Ltd [1]) You are working a busy shift in your department’s fast track area and sign up for a patient with a complaint of “eye pain.” The patient is a fan of glue-on nails and mistook her nail glue bottle for her eyedrops. Now she is unable to open her eyelid for the exam and you struggle to open it yourself.

Packaging 130
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Tracking the bird flu, experts see a familiar threat — and a virus whose course is hard to predict

STAT

Veteran influenza epidemiologist Keiji Fukuda remembers vividly when he first became fearful that a virulent bird flu virus, H5N1, might be on the verge of triggering a devastating pandemic. The virus, seemingly out of nowhere, did something bird flu viruses were thought not to be able to do. It infected 18 people, killing six of them. That happened in 1997, in Hong Kong.

340
340
article thumbnail

Woman of the Week: KaliVir Immunotherapeutics’ Helena Chaye

PharmaVoice

The triple threat CEO — scientist, lawyer and biotech pro — thinks she’s discovered a key to curing a wide range of cancers.

239
239

More Trending

article thumbnail

Black History Month: Pharmacy Trailblazers

Pharmacy Is Right For Me

February marks Black History Month in the United States. We want to take this opportunity to recognize some Black pharmacists who have made significant contributions to the pharmacy field. James McCune Smith James McCune Smith was born into slavery in 1813. He earned his medical degree from Glasgow University. He is recognized as the first African American to earn a medical degree, the first to be published in American medical journals, as well as the first African American to own and operate a

article thumbnail

STAT+: Bayer, facing investor ire, appoints an outsider CEO

STAT

Bayer named former Roche executive Bill Anderson as its new CEO on Wednesday, potentially ending a dramatic and difficult chapter during which its current chief executive, Werner Baumann, presided over the disastrous $63 billion purchase of the agriculture firm Monsanto. Anderson will take over April 1, becoming the first American to run the 160-year-old conglomerate, which invented aspirin and later played a major role in the development of hormonal contraceptives, hemophilia clotting factors,

306
306
article thumbnail

United by inequity: The healthcare disparities plaguing rare disease patients and Black Americans

PharmaVoice

Guided by her personal experiences, Tamar Thompson is aiming to improve rare disease care through her advocacy work at Alexion, AstraZeneca Rare Disease.

211
211
article thumbnail

Vygon and University hospital of Wales in heart patient partnership

Pharma Times

Collaboration has created method for heart failure patients to receive at-home treatment

Hospitals 142
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Scottish biotech aims to cure common cold

Pharmafile

Scottish biotech company ScotBio has announced that it has seen “promising initial results” from its attempts to extract a cure for the common cold from algae. The Livingston-based company is assessing how waste molecules from spirulina, an algae often consumed as a superfood, could be used as a cure for the common cold, COVID-19 and various other viruses.

article thumbnail

STAT+: Pharma loses a court battle in its bid to block states from importing drugs from Canada

STAT

In a setback to the pharmaceutical industry, a federal judge has tossed a lawsuit that sought to prevent state governments from importing medicines from Canada. The decision is likely to embolden more states to now consider the approach as they look to lower the cost of prescription drugs In a 26-page opinion , U.S. District Court Judge Timothy Kelly ruled that drug companies failed to prove they would face a “concrete risk of harm” from a federal rule that would allow states to im

article thumbnail

Why are there gaps in mental healthcare? Often it’s flawed trial methodology

PharmaVoice

Sunovion Pharmaceuticals has developed a more precise way to track symptoms that could be broadly adopted across the industry.

147
147
article thumbnail

Positive data from LEO Pharma’s delgocitinib cream trial

Pharma Times

Study involves the treatment of adults with moderate-to-severe chronic hand eczema

137
137
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Five potential EU regulatory changes impacting the life sciences industry in 2023

European Pharmaceutical Review

A wave of important legislative changes is anticipated in the EU in 2023 making this year one of the biggest for the EU regulatory landscape governing the life sciences industry in recent times. Changes have been spurred by the COVID-19 pandemic, which emphasised the need to urgently modernise outdated EU pharmaceutical law and revise regulatory ambitions in the MedTech sector.

Packaging 117
article thumbnail

Seizure drug offers hope of expanding the pool of donor hearts

STAT

The moment a donor heart is cut off from its blood supply, transplant teams are on a race against the clock to remove it, transport it, and sew it into the recipient, all within four hours. A new way of reprogramming donor hearts could give them more time. A study published Wednesday in Science Translational Medicine finds that when valproic acid, a medication to treat seizures, is infused in donor hearts, it could significantly extend — potentially double — the safe storage time o

279
279
article thumbnail

Rocket Pharmaceuticals is ready for liftoff in the rare disease space

PharmaVoice

With two rare disease products on the launch pad for FDA submission in 2023 and a growing pipeline, Rocket is fueled for its next era of growth.

147
147
article thumbnail

Pharmacists to receive further mental health training

Pharma Times

The pathway is a programme designed to develop pharmacists’ knowledge of mental health among patients

137
137
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Astellas and Bayer announce management changes

European Pharmaceutical Review

Changes to management for Big Pharma companies Astellas and Bayer AG have been announced for 2023. Astellas Astellas Pharma Inc. has approved changes of its Representative Director, President and CEO and its management structure. Effective April 1, 2023, Naoki Okamura and Kenji Yasukawa will hold the following positions: Naoki Okamura is currently Representative Director, Executive Vice President of Astellas.

105
105
article thumbnail

After ‘losing my life’ caring for a sick partner, a professor examines the U.S. caregiver crisis

STAT

“Living With”  explores the contours of life with chronic illness, from the prelude to diagnosis to new patterns of living, to wrestling with big questions about illness and health. Laura Mauldin was immersed in Deaf culture from childhood — but she’s not deaf. She went to a school that happened to educate many deaf children, and so she grew up learning American Sign Language.

279
279
article thumbnail

Entact Bio’s CEO is leading the company out of stealth and into a new age of protein enhancement

PharmaVoice

Victoria Richon’s latest venture is in the burgeoning field of protein-regulated drugs that could target a range of diseases.

147
147
article thumbnail

Vital funding established for Evonetix projects

Pharma Times

Financing will allow company’s development of DNA synthesis chip technology to commercial scale

136
136
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

4D Molecular’s Fabry gene therapy program on FDA clinical hold

Pharmaceutical Technology

4D Molecular Therapeutics (4DMT), the California-based biotechnology company focused on developing gene therapies for rare and large market diseases, has had the FDA place a clinical hold onto its Fabry disease (FD) gene therapy program (4D-310). 4DMT had paused enrollment of patients to two of its trials for 4D-310 last month following a significant adverse event where three patients experienced kidney issues; however, these were treated and resolved in a four-week period. 4DMT has stated that

105
105
article thumbnail

STAT+: How the CPAP crisis has paved the way for Philips’ biggest rivals to rake in profits

STAT

The Philips respiratory machine recall is a no-win situation for patients and doctors. But for the medical device giant’s longtime rivals and new competitors, business is looking up. “We think it will be difficult for Philips to regain all the share that they had,” said Margaret Kaczor, an analyst with William Blair who follows ResMed among other companies.

264
264
article thumbnail

Bayer, Astellas switch CEOs amid major inflection points

PharmaVoice

Bayer’s Bill Anderson and Astellas’ Naoki Okamura will be charged with setting the companies on growth trajectories for 2023.

130
130
article thumbnail

Alvotech and Advanz link-up for Xolair drive

Pharma Times

Alvotech will be responsible for supply and Advanz will oversee commercialisation of biosimilar

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Pharma Governance and the Quest for Gender Equity

PharmExec

Examining efforts to boost women representation on company boards.

105
105
article thumbnail

STAT+: Verily, struggling to turn profits, taps a Starbucks veteran and ‘Warcraft’ master

STAT

The newly-minted CEO of the Alphabet health tech spinout Verily is not a doctor or a Ph.D. scientist. He’s never run a top-flight lab or published a seminal paper in health care. His breakthrough executive job, far from the halls of science or medicine, was at Starbucks. But Stephen Gillett, 47, now finds himself in charge of one of the most ambitious (some would say overhyped) efforts to transform American health care with technology.

264
264
article thumbnail

The unique playbook of Biohaven’s CEO

PharmaVoice

Vlad Coric’s offbeat business strategy paid off once with a Pfizer buyout. Can he do it again?

130
130
article thumbnail

NICE fails to recommend Boehringer Ingelheim and Lilly Alliance’s empagliflozin

Pharma Times

The treatment has been developed to treat certain chronic heart failure patients and is approved elsewhere

130
130
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.